JNJ

226.93

+0.85%↑

ABT

106.07

-1.07%↓

MDT

100.83

-0.99%↓

A

134.66

-0.93%↓

VEEV

216.9

-1.31%↓

JNJ

226.93

+0.85%↑

ABT

106.07

-1.07%↓

MDT

100.83

-0.99%↓

A

134.66

-0.93%↓

VEEV

216.9

-1.31%↓

JNJ

226.93

+0.85%↑

ABT

106.07

-1.07%↓

MDT

100.83

-0.99%↓

A

134.66

-0.93%↓

VEEV

216.9

-1.31%↓

JNJ

226.93

+0.85%↑

ABT

106.07

-1.07%↓

MDT

100.83

-0.99%↓

A

134.66

-0.93%↓

VEEV

216.9

-1.31%↓

JNJ

226.93

+0.85%↑

ABT

106.07

-1.07%↓

MDT

100.83

-0.99%↓

A

134.66

-0.93%↓

VEEV

216.9

-1.31%↓

Search

Intuitive Surgical Inc

Open

SectorHealthcare

521.65 -0.61

Overview

Share price change

24h

Current

Min

521.59

Max

528.83

Key metrics

By Trading Economics

Income

45M

709M

Sales

361M

2.9B

P/E

Sector Avg

67.108

90.422

Profit margin

28.31

Employees

15,638

EBITDA

-60M

956M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+24.32% upside

Dividends

By Dow Jones

Next Earnings

21 kwi 2026

Market Stats

By TradingEconomics

Market Cap

-2.2B

190B

Previous open

522.26

Previous close

521.65

News Sentiment

By Acuity

26%

74%

54 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Intuitive Surgical Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

21 paź 2025, 23:55 UTC

Hot Stocks

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 paź 2025, 21:14 UTC

Earnings
Major Market Movers

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 paź 2025, 20:38 UTC

Earnings

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 lip 2025, 21:13 UTC

Earnings

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

23 sty 2026, 16:07 UTC

Earnings

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

23 sty 2026, 12:58 UTC

Earnings

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

22 sty 2026, 21:11 UTC

Earnings

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 sty 2026, 21:11 UTC

Earnings

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 sty 2026, 21:10 UTC

Earnings

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 sty 2026, 21:05 UTC

Earnings

Intuitive Surgical 4Q EPS $2.21 >ISRG

22 sty 2026, 21:05 UTC

Earnings

Intuitive Surgical 4Q Rev $2.87B >ISRG

22 sty 2026, 21:05 UTC

Earnings

Intuitive Surgical 4Q Net $794.8M >ISRG

22 sty 2026, 21:05 UTC

Earnings

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

22 sty 2026, 21:05 UTC

Earnings

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

30 paź 2025, 12:38 UTC

Earnings

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 paź 2025, 12:01 UTC

Earnings

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 paź 2025, 15:42 UTC

Earnings

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 paź 2025, 12:34 UTC

Earnings

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 paź 2025, 11:49 UTC

Earnings

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 paź 2025, 20:08 UTC

Earnings

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 paź 2025, 20:08 UTC

Earnings

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 paź 2025, 20:05 UTC

Earnings

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 paź 2025, 20:05 UTC

Earnings

Intuitive Surgical 3Q Net $704.4M >ISRG

21 paź 2025, 20:05 UTC

Earnings

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 paź 2025, 20:05 UTC

Earnings

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 paź 2025, 20:05 UTC

Earnings

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 lip 2025, 20:14 UTC

Earnings

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 lip 2025, 20:13 UTC

Earnings

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 lip 2025, 20:13 UTC

Earnings

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 lip 2025, 20:05 UTC

Earnings

Intuitive Surgical 2Q Net $658.4M >ISRG

Peer Comparison

Price change

Intuitive Surgical Inc Forecast

Price Target

By TipRanks

24.32% upside

12 Months Forecast

Average 652.73 USD  24.32%

High 750 USD

Low 550 USD

Based on 18 Wall Street analysts offering 12 month price targets forIntuitive Surgical Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

18 ratings

14

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

514.59 / 539.05Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

54 / 352 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat